MiRNA expression in colon polyps provides evidence for a Multihit model of colon cancer

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Oberg, Ann L ^a   French, Amy J ^a   Sarver, Aaron L ^b   Subramanian, Subbaya ^c   Morlan, Bruce W ^a   Riska, Shaun M ^a   Borralho, Pedro M ^d   Cunningham, Julie M ^a   Boardman, Lisa A ^a   Wang, Liang ^a   Smyrk, Thomas C ^a   Asmann, Yan ^a   Steer, Clifford J ^c   Thibodeau, Stephen N ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF LISBON   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 135B; MICRORNA 137; MICRORNA 224; MICRORNA 31; MICRORNA 552; MICRORNA 592; MICRORNA 9; MICRORNA 99A; PROTEIN MLH1; UNCLASSIFIED DRUG;

ARTICLE; BASE MISPAIRING; CANCER GROWTH; CANCER MODEL; CANCER STAGING; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CANCER; COLON POLYP; CONTROLLED STUDY; DNA METHYLATION; DNA REPAIR; DOWN REGULATION; FAMILIAL CANCER; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN TISSUE; INHERITANCE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MLH1 GENE; ONSET AGE; PROMOTER REGION; UPREGULATION; ADENOMA; BIOLOGICAL MODEL; CHROMOSOME 14; CLUSTER ANALYSIS; COLON; COLON TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS;

ADENOMA; CHROMOSOMES, HUMAN, PAIR 14; CLUSTER ANALYSIS; COLON; COLONIC NEOPLASMS; COLONIC POLYPS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; PRINCIPAL COMPONENT ANALYSIS;

EID: 79958270237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020465     Document Type: Article

References (55)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
2. Boland CR, Goel A, (2010) Microsatellite instability in colorectal cancer. Gastroenterology 138: 2073-2087.e2073.
3. Poulogiannis G, Frayling IM, Arends MJ, (2010) DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Histopathology 56: 167-179.
4. Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN, (2005) Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch syndrome. Fam Cancer 4: 255-265.
5. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, et al. (1998) A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257.
6. Popat S, Hubner R, Houlston RS, (2005) Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol 23: 609-618.
7. Grady WM, (2004) Genomic instability and colon cancer. Cancer Metastasis Rev 23: 11-27.
8. Kemp Z, Thirlwell C, Sieber O, Silver A, Tomlinson I, (2004) An update on the genetics of colorectal cancer. Hum Mol Genet 13 Spec No 2: R177-R185.
9. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
10. Inui M, Martello G, Piccolo S, (2010) MicroRNA control of signal transduction. Nat Rev Mol Cell Biol 11: 252-263.
11. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714.
12. Bandrés E, Cubedo E, Agirre X, Malumbres R, Zárate R, et al. (2006) Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29.
13. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, et al. (2008) Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 68: 6416-6424.
14. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, et al. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299: 425-436.
15. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, et al. (2007) Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 72: 397-402.
16. Sarver AL, French AJ, Borralho PM, Thayanithy V, Oberg AL, et al. (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 18: 401.
17. Lanza G, Ferracin M, Gafa R, Veronese A, Spizzo R, et al. (2007) mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 6: 54.
18. Earle JS, Luthra R, Romans A, Abraham R, Ensor J, et al. (2010) Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J Mol Diagn 12: 433-440.
19. Slattery ML, Wolff E, Hoffman MD, Pellatt DF, Milash B, et al. (2011) MicroRNAs and colon and rectal cancer: differential expression by tumor location and subtype. Genes Chromosomes Cancer 50: 196-206.
20. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, et al. (2009) Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 34: 1069-1075.
21. Balaguer F, Link A, Lozano JJ, Cuatrecasas M, Nagasaka T, et al. (2010) Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res 70: 6609-6618.
22. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, et al. (2009) MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 101: 707-714.
23. Schmitz KJ, Hey S, Schinwald A, Wohlschlaeger J, Baba HA, et al. (2009) Differential expression of microRNA 181b and microRNA 21 in hyperplastic polyps and sessile serrated adenomas of the colon. Virchows Arch 455: 49-54.
24. Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, et al. (2008) Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 68: 5795-5802.
25. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ, (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891.
26. Chen J, Lozach J, Garcia EW, Barnes B, Luo S, et al. (2008) Highly sensitive and specific microRNA expression profiling using BeadArray technology. Nucleic Acids Res 36: e87.
27. Dukes C, (1937) Histological Grading of Rectal Cancer: (Section of Pathology). Proc R Soc Med 30: 371-376.
28. Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, et al. (2001) The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69: 780-790.
29. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, et al. (2002) Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 20: 1043-1048.
30. Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, et al. (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58: 3455-3460.
31. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
32. Eckel JE, Gennings C, Therneau TM, Burgoon LD, Boverhof DR, et al. (2005) Normalization of two-channel microarray experiments: a semiparametric approach. Bioinformatics 21: 1078-1083.
33. Johnson WE, Li C, Rabinovic A, (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127.
34. Gentleman R, Huber V, Irizarry RA, Dudoit S, (2005) Bioinformatics and computational biology solutions using R and bioconductor. New York Springer New York.
35. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 57: 289-300.
36. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 100: 9440-9445.
37. Partek Inc, (2008) Partek® Genomics Suite™. Revision 63. St. Louis: Partek Inc.
38. R Development Core Team (2008) R: A language and environment for statistical computing. Vienna, Austria.
39. Cunningham JM, Oberg AL, Borralho PM, Kren BT, French AJ, et al. (2009) Evaluation of a new high-dimensional miRNA profiling platform. BMC Med Genomics 2: 57.
40. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, et al. (2010) Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One 5.
41. Valastyan S, Weinberg RA, (2010) miR-31: A crucial overseer of tumor metastasis and other emerging roles. Cell Cycle 9: 2124-2129.
42. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233.
43. Subramanian S, Lui WO, Lee CH, Espinosa I, Nielsen TO, et al. (2008) MicroRNA expression signature of human sarcomas. Oncogene 27: 2015-2026.
44. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J, (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68: 2094-2105.
45. Silber J, Lim DA, Petritsch C, Persson AI, Maunakea AK, et al. (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6: 14.
46. Fodde R, (2002) The APC gene in colorectal cancer. Eur J Cancer 38: 867-871.
47. Sarver AL, Li L, Subramanian S, (2010) MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 70: 9570-9580.
48. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, et al. (2004) A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 14: 1741-1748.
49. Takahashi N, Okamoto A, Kobayashi R, Shirai M, Obata Y, et al. (2009) Deletion of Gtl2, imprinted non-coding RNA, with its differentially methylated region induces lethal parent-origin-dependent defects in mice. Hum Mol Genet 18: 1879-1888.
50. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 9: 435-443.
51. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, et al. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 105: 7004-7009.
52. Sarver AL, Phalak R, Thayanithy V, Subramanian S, (2010) S-MED: sarcoma microRNA expression database. Lab Invest 90: 753-761.
53. Stadtfeld M, Apostolou E, Akutsu H, Fukuda A, Follett P, et al. (2010) Aberrant silencing of imprinted genes on chromosome 12qFn mouse induced pluripotent stem cells. Nature 465: 175-181.
54. Staub E, Gröne J, Mennerich D, Röpcke S, Klamann I, et al. (2006) A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 5: 37.
55. Trautmann K, Terdiman JP, French AJ, Roydasgupta R, Sein N, et al. (2006) Chromosomal instability in microsatellite-unstable and stable colon cancer. Clin Cancer Res 12: 6379-6385.